ACTIVE

Upjohn

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
850 k €
+8.8% YoY
Equity
12,1 M €
+7.6% YoY

What does Upjohn do?

Upjohn is a Private limited company incorporated in 2014. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Hoeilaart.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0552.558.025
Incorporation
09/05/2014
Legal form
Private limited company
Registered office
Terhulpsesteenweg 6A
1560 Hoeilaart · FlandreSee on map
Contributed capital
6 437 478,01 €
Latest accounts
31/12/2025
Activities (NACE)
21201Manufacture of pharmaceutical preparations· main21201Manufacture of pharmaceutical preparations46460Wholesale of pharmaceutical goods46460Wholesale of pharmaceutical goods
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 4 financial years

2025202420232022
Income statement
Revenue––4,8 k €23,5 M €
EBITDA920,5 k €730,2 k €788,1 k €256,8 k €
Operating result920,5 k €730,2 k €788,1 k €1 M €
Net result850 k €781,1 k €889,3 k €773,4 k €
Balance sheet
Equity12,1 M €11,2 M €10,5 M €16,6 M €
Total assets12,3 M €11,7 M €11,1 M €25,1 M €
Cash0 €171,6 k €172,3 k €1,2 M €
Debts252,1 k €468,9 k €628,9 k €8,6 M €
Other
Workforce–––4,4 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

NARAYAN Arun

Director · since 26 novembre 2025

Active
BUCZEK Tomasz

Director · since 25 juin 2025

Active

Ended mandates

Salzmann Matthew

Director · since 01 mars 2024

Ended
Luis Birbuet

Director · since 29 mars 2021

Ended
Verschraegen Vincent

Director · since 05 février 2021

Ended
At this address

Other companies at this address

CompanyCBE no.
AKTUAPHARMA● Active
0463.582.004
Viatris GX● Active
0885.805.780
Viatris Healthcare● Active
0403.048.064
Viatris International Supply Point● Active
0463.648.419
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/12/202101/12/202001/12/2019
Closing of the financial year31/12/202531/12/202431/12/202331/12/202230/11/202130/11/2020
Length of the financial year12 months12 months12 months13 months12 months12 months
Filing date07/07/202627/06/202527/06/202403/08/202309/06/202203/06/2021
General meeting18/06/202619/06/202520/06/202428/06/202331/05/202219/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

11 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202518/06/202607/07/2026DutchPDF
Full model31/12/202419/06/202527/06/2025DutchPDF
Full model31/12/202320/06/202427/06/2024FrenchPDF
Full model31/12/202228/06/202303/08/2023FrenchPDF
Full model30/11/202131/05/202209/06/2022FrenchPDF
Full model30/11/202019/05/202103/06/2021FrenchPDF
Full model30/11/201920/05/202029/06/2020FrenchPDF
Full model30/11/201815/05/201922/05/2019FrenchPDF
Full model30/11/201716/05/201830/05/2018FrenchPDF
Full model30/11/201617/05/201709/06/2017FrenchPDF
Full model30/11/201518/05/201615/06/2016FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

NARAYAN Arun

Director · since 26 novembre 2025

Active
BUCZEK Tomasz

Director · since 25 juin 2025

Active

Ended mandates

Salzmann Matthew

Director · since 01 mars 2024

Ended
Luis Birbuet

Director · since 29 mars 2021

Ended
Verschraegen Vincent

Director · since 05 février 2021

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other02/07/2026
    —
    PDF
  • Mandates10/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/07/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates01/07/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office14/08/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - SIEGE SOCIAL
    PDF
  • Mandates21/03/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates05/01/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Other14/11/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025850 k €↑
  2. 2024
    Annual accounts 2024781,1 k €↓
  3. 2023
    Annual accounts 2023889,3 k €↑
  4. 2022
    Annual accounts 2022773,4 k €
  5. 09/05/2014
    IncorporationPrivate limited company